Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T18:25:18.841Z.
Calculation as of: 2026-10-06T18:25:18.841Z.
Quote observation: 2026-10-06T18:25:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f1b69e3b66f27443032d61e4b8b82fea4bf8ea9e73a5af38069dd33813f2151d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-08-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
4.58x
EV/FCF RATIO AVG 3Y
4.76x
EV/FCF RATIO AVG 5Y
4.76x
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$256.15M
EV/FCF Ratio
428.92x
TTM Avg
210.95x
3Y Avg
227.91x
5Y Avg
182.13x
Market Cap
$261.08M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.81M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.82M
EV/FCF Ratio
N/A
TTM Avg
0.65x
3Y Avg
2.46x
5Y Avg
493.92x
Market Cap
$264.74M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AC Immune S.A. (ACIU) | $257.03M | N/A | 4.58x | 4.76x | 4.76x |
| Anika Therapeutics, Inc. (ANIK)vs › | $256.15M | 428.92x | 210.95x | 227.91x | 182.13x |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $261.08M | N/A | N/A | N/A | N/A |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $260.56M | N/A | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $262.75M | N/A | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $261.81M | N/A | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $261.82M | N/A | 0.65x | 2.46x | 493.92x |
| Upstream Bio, Inc. (UPB)vs › | $250.88M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.74M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $264.52M | N/A | 48.59x | 48.59x | 48.59x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2025-08-05 | 4.65x |
| 2025-08-04 | 4.12x |
| 2025-08-01 | 3.98x |
| 2025-07-31 | 4.06x |
| 2025-07-30 | 4.10x |
| 2025-07-29 | 4.45x |
| 2025-07-28 | 4.49x |
| 2025-07-25 | 4.61x |
| 2025-07-24 | 4.61x |
| 2025-07-23 | 4.43x |
| 2025-07-22 | 4.37x |
| 2025-07-21 | 3.90x |
| 2025-07-18 | 3.88x |
| 2025-07-17 | 3.88x |
| 2025-07-16 | 3.86x |
| 2025-07-15 | 3.84x |
| 2025-07-14 | 3.90x |
| 2025-07-11 | 3.82x |
| 2025-07-10 | 3.96x |
| 2025-07-09 | 3.90x |
| 2025-07-08 | 3.88x |
| 2025-07-07 | 3.71x |
| 2025-07-03 | 3.88x |
| 2025-07-02 | 3.77x |
| 2025-07-01 | 3.69x |
| 2025-06-30 | 3.79x |
| 2025-06-27 | 3.75x |
| 2025-06-26 | 3.92x |
| 2025-06-25 | 3.88x |
| 2025-06-24 | 3.96x |
| 2025-06-23 | 3.39x |
| 2025-06-20 | 3.49x |
| 2025-06-18 | 3.69x |
| 2025-06-17 | 3.57x |
| 2025-06-16 | 3.61x |
| 2025-06-13 | 3.63x |
| 2025-06-12 | 3.88x |
| 2025-06-11 | 3.98x |
| 2025-06-10 | 4.14x |
| 2025-06-09 | 3.94x |
| 2025-06-06 | 3.82x |
| 2025-06-05 | 3.18x |
| 2025-06-04 | 3.06x |
| 2025-06-03 | 3.02x |
| 2025-06-02 | 3.02x |
| 2025-05-30 | 3.14x |
| 2025-05-29 | 3.12x |
| 2025-05-28 | 3.08x |
| 2025-05-27 | 3.10x |
| 2025-05-23 | 3.10x |
| 2025-05-22 | 3.12x |
| 2025-05-21 | 3.02x |
| 2025-05-20 | 3.22x |
| 2025-05-19 | 3.20x |
| 2025-05-16 | 3.14x |
| 2025-05-15 | 2.86x |
| 2025-05-14 | 2.78x |
| 2025-05-13 | 2.86x |
| 2025-05-12 | 2.98x |
| 2025-05-09 | 3.08x |
| 2025-05-08 | 3.04x |
| 2025-05-07 | 3.04x |
| 2025-05-06 | 2.96x |
| 2025-05-05 | 3.14x |
| 2025-05-02 | 3.16x |
| 2025-05-01 | 3.06x |
| 2025-04-30 | 1.96x |
| 2025-04-29 | 1.91x |
| 2025-04-28 | 1.91x |
| 2025-04-25 | 1.83x |
| 2025-04-24 | 1.86x |
| 2025-04-23 | 1.75x |
| 2025-04-22 | 1.63x |
| 2025-04-21 | 1.61x |
| 2025-04-17 | 1.61x |
| 2025-04-16 | 1.63x |
| 2025-04-15 | 1.65x |
| 2025-04-14 | 1.66x |
| 2025-04-11 | 1.72x |
| 2025-04-10 | 1.61x |
| 2025-04-09 | 1.68x |
| 2025-04-08 | 1.65x |
| 2025-04-07 | 1.76x |
| 2025-04-04 | 1.86x |
| 2025-04-03 | 2.01x |
| 2025-04-02 | 2.17x |
| 2025-04-01 | 2.05x |
| 2025-03-31 | 2.15x |
| 2025-03-28 | 2.31x |
| 2025-03-27 | 2.34x |
| 2025-03-26 | 2.32x |
| 2025-03-25 | 2.31x |
| 2025-03-24 | 2.50x |
| 2025-03-21 | 2.48x |
| 2025-03-20 | 2.56x |
| 2025-03-19 | 2.64x |
| 2025-03-18 | 2.67x |
| 2025-03-17 | 2.63x |
| 2025-03-14 | 2.74x |
| 2025-03-13 | 4.29x |
| 2025-03-12 | 4.34x |
| 2025-03-11 | 4.18x |
| 2025-03-10 | 4.51x |
| 2025-03-07 | 4.53x |
| 2025-03-06 | 4.71x |
| 2025-03-05 | 4.73x |
| 2025-03-04 | 4.40x |
| 2025-03-03 | 4.51x |
| 2025-02-28 | 4.82x |
| 2025-02-27 | 4.84x |
| 2025-02-26 | 4.78x |
| 2025-02-25 | 4.89x |
| 2025-02-24 | 4.95x |
| 2025-02-21 | 5.06x |
| 2025-02-20 | 5.08x |
| 2025-02-19 | 5.15x |
| 2025-02-18 | 5.04x |
| 2025-02-14 | 5.26x |
| 2025-02-13 | 5.13x |
| 2025-02-12 | 4.56x |
| 2025-02-11 | 4.82x |
| 2025-02-10 | 4.97x |
| 2025-02-07 | 5.15x |
| 2025-02-06 | 5.15x |
| 2025-02-05 | 5.17x |
| 2025-02-04 | 5.24x |
| 2025-02-03 | 5.17x |
| 2025-01-31 | 5.28x |
| 2025-01-30 | 5.17x |
| 2025-01-29 | 5.04x |
| 2025-01-28 | 5.04x |
| 2025-01-27 | 5.08x |
| 2025-01-24 | 5.24x |
| 2025-01-23 | 5.17x |
| 2025-01-22 | 5.19x |
| 2025-01-21 | 5.06x |
| 2025-01-17 | 5.13x |
| 2025-01-16 | 5.04x |
| 2025-01-15 | 5.13x |
| 2025-01-14 | 4.97x |
| 2025-01-13 | 4.97x |
| 2025-01-10 | 5.21x |
| 2025-01-08 | 5.39x |
| 2025-01-07 | 5.68x |
| 2025-01-06 | 5.79x |
| 2025-01-03 | 5.79x |
| 2025-01-02 | 5.50x |
| 2024-12-31 | 5.17x |
| 2024-12-30 | 5.11x |
| 2024-12-27 | 5.24x |
| 2024-12-26 | 5.19x |
| 2024-12-24 | 5.13x |
| 2024-12-23 | 5.13x |
| 2024-12-20 | 5.13x |
| 2024-12-19 | 5.17x |
| 2024-12-18 | 5.32x |
| 2024-12-17 | 5.70x |
| 2024-12-16 | 5.65x |
| 2024-12-13 | 5.72x |
| 2024-12-12 | 5.81x |
| 2024-12-11 | 6.09x |
| 2024-12-10 | 6.14x |
| 2024-12-09 | 6.14x |
| 2024-12-06 | 6.16x |
| 2024-12-05 | 6.22x |
| 2024-12-04 | 6.27x |
| 2024-12-03 | 6.29x |
| 2024-12-02 | 6.29x |
| 2024-11-29 | 6.71x |
| 2024-11-27 | 6.62x |
| 2024-11-26 | 6.71x |
| 2024-11-25 | 6.73x |
| 2024-11-22 | 6.66x |
| 2024-11-21 | 6.47x |
| 2024-11-20 | 6.36x |
| 2024-11-19 | 6.42x |
| 2024-11-18 | 6.14x |
| 2024-11-15 | 6.25x |
| 2024-11-14 | 7.04x |
| 2024-11-13 | 6.11x |
| 2024-11-12 | 5.96x |
| 2024-11-11 | 6.20x |
| 2024-11-08 | 6.27x |
| 2024-11-07 | 6.42x |
| 2024-11-06 | 6.03x |
| 2024-11-05 | 5.59x |
| 2024-11-04 | 4.97x |
| 2024-11-01 | 5.10x |
| 2024-10-31 | 4.76x |
| 2024-10-30 | 5.03x |
| 2024-10-29 | 5.12x |
| 2024-10-28 | 5.10x |
| 2024-10-25 | 5.20x |
| 2024-10-24 | 5.10x |
| 2024-10-23 | 5.18x |
| 2024-10-22 | 5.32x |
| 2024-10-21 | 5.24x |
| 2024-10-18 | 5.36x |
| 2024-10-17 | 5.53x |
| 2024-10-16 | 5.49x |
| 2024-10-15 | 5.51x |
| 2024-10-14 | 5.49x |
| 2024-10-11 | 5.76x |
| 2024-10-10 | 5.80x |
| 2024-10-09 | 5.90x |
| 2024-10-08 | 5.74x |
| 2024-10-07 | 5.92x |
| 2024-10-04 | 5.88x |
| 2024-10-03 | 5.90x |
| 2024-10-02 | 6.09x |
| 2024-10-01 | 6.65x |
| 2024-09-30 | 6.71x |
| 2024-09-27 | 6.65x |
| 2024-09-26 | 6.55x |
| 2024-09-25 | 6.53x |
| 2024-09-24 | 6.59x |
| 2024-09-23 | 6.46x |
| 2024-09-20 | 6.53x |
| 2024-09-19 | 6.53x |
| 2024-09-18 | 6.40x |
| 2024-09-17 | 6.05x |
| 2024-09-16 | 5.66x |
| 2024-09-13 | 5.47x |
| 2024-09-12 | 5.20x |
| 2024-09-11 | 5.22x |
| 2024-09-10 | 5.26x |
| 2024-09-09 | 5.20x |
| 2024-09-06 | 5.07x |
| 2024-09-05 | 5.32x |
| 2024-09-04 | 5.34x |
| 2024-09-03 | 5.22x |
| 2024-08-30 | 5.57x |
| 2024-08-29 | 5.57x |
| 2024-08-28 | 5.39x |
| 2024-08-27 | 5.22x |
| 2024-08-26 | 5.43x |
| 2024-08-23 | 5.26x |
| 2024-08-22 | 5.22x |
| 2024-08-21 | 5.84x |
| 2024-08-20 | 5.88x |
| 2024-08-19 | 5.95x |
| 2024-08-16 | 5.86x |
| 2024-08-15 | 5.90x |
| 2024-08-14 | 5.70x |
| 2024-08-13 | 6.09x |
| 2024-08-12 | 5.90x |
| 2024-08-09 | 5.68x |
| 2024-08-08 | 6.01x |
| 2024-08-07 | 5.80x |
| 2024-08-06 | 6.19x |
| 2024-08-05 | 6.11x |
| 2024-08-02 | 6.38x |
| 2024-08-01 | 6.80x |
| 2024-07-31 | 7.35x |
| 2024-07-30 | 7.58x |
| 2024-07-29 | 7.27x |
| 2024-07-26 | 6.98x |
| 2024-07-25 | 6.98x |
| 2024-07-24 | 6.19x |
| 2024-07-23 | 6.53x |
Showing the most recent 260 of 556 data points. The chart above shows the full history.
